EAPM Congress and all-island trial collaboration

Following our work with InterTrade Ireland to promote all-island cancer trial collaboration our Clinical Lead, Prof Bryan Hennessy, will be co-chairing the session “Discover What’s Possible – The opportunities and challenges of all-island cancer clinical trial collaboration” at EAPM’s first major European Personalised Medicine Congress which will be hosted in Belfast next week (27-30 Nov) eapmbelfast2017.com/ Check […]

Just published in Lancet Oncology

The findings of the SOLE trial have just been published in Lancet Oncology with Dr Seamus O’Reilly, consultant medical oncologist at Cork-Mercy and South Infirmary Victoria University Hospitals as one of the authors.  Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial In […]


Funding of up to €300,000 is available for projects from 12 up to 36 months under the MRCG-HRB Joint Funding Scheme from Breakthrough Cancer Research. Breakthrough Cancer Research (Breakthrough) is an Irish Medical Cancer Research Charity focused on funding research leading to new treatments for cancers which do not respond or are poorly served by available […]

Cancer Care in Primary Care

50 fully funded places. For primary healthcare professionals including doctors, nurses and pharmacists. 7-week course, 26 learning hours, to further your knowledge and career in cancer care management in primary care. The course is provided by iheed, a leading medical education technology company, in conjunction with the Department of General Practice at University College Cork […]

Prostate trial extended

The first large scale trial to test the benefits of using a specialised type of radiotherapy to treat early stage prostate cancer has been extended to include St Luke’s Radiation Oncology Network (SLRON) in Dublin. The trial was opened in Beacon Hospital, Dublin, earlier this year, The PACE trial is being led internationally by The […]

Targets need funding

The CEO of Cancer Trials Ireland says that the ambitions cancer trials research targets in new cancer strategy will remain aspirations if not funded.   The National Cancer Strategy is a potential game changer. Its implementation could take us significantly closer to finding successful treatments for all types of cancer. We are very pleased with […]

DSSG meeting gallery

Speakers and delegates. Michael Conroy, Dept of Health, Dr Nicola Elmer, Senior Psychologist, St Luke’s Hospital, Prof Bryan Hennessy,  Clinical Lead, Cancer Trials Ireland, Eibhlin Mulroe, CEO, Cancer Trials Ireland & Dr Jerome Coffey, Director, NCCP. Michael Conroy, Head of the Cancer, Blood and Organs Policy Unit at the Dept. of Health, Dr Nicola Elmer, […]